Participants
Ethical aspects of this study were reviewed and approved by the Human Research Ethics Committee at the Ashikaga Red Cross Hospital. This study was performed after obtaining informed consent from all participants upon admission. For patients below the age of 18 years, informed parental consent was also obtained. Diagnosis was based on criteria in the ICD-10, and each patient was diagnosed by two of the three psychiatrists, each of whom is a board certified specialist for psychiatry and had > 10 years of experience in psychiatry at the time of the study. Participants were recruited from the neuropsychiatric unit in Ashikaga Rec Cross Hospital during the period from April 2003 to March 2018, during which there were 90 admissions with eating disorders that were managed in our unit. These were categorized into the restrictive type (F50.0, anorexia nervosa) and the binge-purge type (F50.2, bulimia nervosa), again by two of the three psychiatrists. One patient was excluded because her serum albumin levels at admission, an indicator of morbidity that leads to malnutrition [21], were not examined. Thus, 89 admissions met the abovementioned criteria and were included in this study for serum potassium levels at admission. Consecutive admissions with recurrences of eating disorders were included as separate admissions [22–24] because weight and nutritional status change with each admission [22]. In this study, among a total of 52 patients, all of whom were Japanese, 16 had two or more consecutive admissions, which added up to a total of 89 admissions.
Regarding nadir hypokalemia, admissions that involved hospitalization for > 1 week were investigated. This is because refeeding syndrome, in particular, electrolyte imbalance, normally occurs within the first week of refeeding [23–25], and because the effect of refeeding on serum potassium levels should be taken into account in this analysis. Among a total of 70 admissions with hospitalization for > 1 week, data from four admissions were excluded because second blood tests were not carried out within 6 days after admission for these individuals: three patients declined repeated blood tests, and one patient underwent the second blood test 8 days after admission. Thus, 66 admissions from 39 independent patients met the abovementioned criteria and were included in this study for the nadir hypokalemia level.
Collection of patient information
Electronic medical records of eligible participants were retrospectively reviewed. As outcome indicators, the following two measures were used: serum potassium levels at admission and nadir potassium levels during the first 2 weeks after admission. Period of the first 2 weeks was applied for the lowest potassium levels because electrolyte imbalance might last for more than 1 week after refeeding in some cases [23]. Explanatory variables included data at admission, i.e., age, sex, body mass index, eating disorder subtype (restrictive or binge-purge), data obtained from laboratory tests (serum albumin level, blood urea nitrogen/creatinine ratio, and serum magnesium levels), and indicators involving treatment, i.e., the rate of weight gain during the first 7 days, caloric intake, and amount of potassium administered. Classification of anorexia nervosa subtype, restrictive or binge-purge (bulimic-type), was carried out because binge-purge behavior, as well as its accompanying laxative/diuretic abuse, often contributes to lower serum potassium levels through repeated vomiting and diarrhea and its associated renal potassium loss in the urine [3, 12, 13]. Body mass index, serum albumin level, and blood urea nitrogen/creatinine ratio were included as explanatory variables because those characteristics have been repeatedly identified as indicators for the severity of refeeding hypophosphatemia [22–24, 26, 27]. A lower body mass index reflects malnutrition itself [21] while a lower serum albumin level indicates morbidity that leads to malnutrition [21]. Backgrounds behind a higher blood urea nitrogen/creatinine ratio include dehydration, protein-energy malnutrition, the catabolic state, and elevated corticosteroid levels, all of which are closely related to the malnutrition found in patients with eating disorders [24]. Body mass index was calculated as the weight of the individual (in kilograms) divided by the square of the height of the individual (in meters). The indicators involving treatment were used because those factors might affect refeeding syndrome [24, 28]. To calculate the rate of weight gain during the first 7 days, we divided the kilograms gained during the first 7 days by the initial weight. Total caloric intake (kilocalories) refers to the average total caloric intake from day 1 through day 7 [23, 24], including both oral intake and intravenous infusion therapy. If the patient ate only half the provided 1200-kcal meal, the actual amount of total caloric intake was reduced to 600 kcal. To accurately investigate the effect of energy intake on an individual patient depending on his or her weight, an indicator of total caloric intake per body weight was used for this analysis (total caloric intake divided by body weight), which is widely used for diet therapy for diabetes mellitus [29]. Potassium administration was defined as the average daily total potassium administration (intravenously and orally combined) from day 1 through day 7 (milliequivalents, mEq). To better calculate the effect of potassium supplementation on refeeding syndrome, the amount of potassium administered was divided by total caloric intake, and this value was used in the statistical analysis. The same method has been applied to the amount of phosphorus administered during the refeeding period in a study on refeeding hypophosphatemia [24]. This is because intracellular movement of serum potassium and phosphorus is considered to be dependent on the reintroduction of nutrients, as it is mediated by surges in insulin [17].
A laboratory panel, including serum potassium levels, was carried out on admission. Regarding the 66 admissions used for the measurement of nadir hypokalemia, each blood test from the second examination onwards was conducted at 7:30 in the morning before breakfast. To precisely identify nadir serum potassium levels, the patients frequently underwent serial laboratory tests: 48 admissions (72.7%) were tested on the second hospital day, 43 (65.1%) on the third hospital day, 43 (65.1%) on the fourth hospital day, 34 (51.5%) on the fifth hospital day, 34 (51.5%) on the sixth hospital day, 29 (43.9%) on the seventh hospital day, and 28 (42.4%) on the eighth hospital day. These patients continued to have blood tests until their serum potassium levels went up again. We note that 60 of 66 admissions (90.9%) had the second laboratory test within 72 h of the first.
Protocol for refeeding and potassium administration
The initial caloric prescription for each patient was decided by individual physicians on admission, based on their assessment of the degree of malnutrition, caloric intake preceding admission, and the weight of each patient. Although caloric intake was administered mainly through oral food (meals and liquid formulas with nutrient compositions), intravenous infusion therapy was sometimes used and, less frequently, nasogastric feeding (liquid formulas with nutrient compositions) was also carried out. Normally, the total initial caloric prescription consisted of ~ 600–1400 kcal/day and was usually increased by ~ 200 kcal every day. Potassium supplementation more than 20 mEq per day was not routinely carried out. However, it was prescribed when hypokalemia (less than 3.5 mEq/L) was found in the laboratory test at admission or in subsequent tests. Intravenous potassium administration was carried out mainly with a normal sugar electrolyte maintenance transfusion solution (10 mEq in a 500-ml transfusion) or an intravenous potassium infusion of ~ 20−30 mEq in 500-mL transfusion solution bags. In the acute phase, potassium administration was prescribed intravenously, whereas oral potassium administration was also carried out, in particular, in the subacute phase. The amount of potassium administration was generally started with ~ 20−40 mEq per day, which was adjusted depending on the levels of serum potassium on serial laboratory tests. This procedure was similarly applied for hypophosphatemia and hypomagnesemia [28].
Statistical analysis
Serum potassium level at admission was investigated from data of 89 admissions (52 independent patients), whereas data from an additional 66 admissions (39 independent patients) with hospitalization for > 1 week were used to determine the nadir hypokalemia during refeeding. Multiple linear regression analysis was used with explanatory variables, including demographics (age, sex, body mass index, and anorexia nervosa subtype, i.e., restrictive or binge-purge), laboratory data obtained at admission (serum albumin level, blood urea nitrogen to creatinine ratio), and treatment-related indicators (caloric intake, amount of potassium administered, and rate of weight gain). The number of patients with laxative/diuretic abuse was 20 according to the electronic medical records, all of whom were included in the binge-purge group, which poses a risk for multicollinearity in the multiple linear regression analysis. The exact number of those patients might have been higher because patients with eating disorders tend to hide such abuse, and a structured interview is needed to precisely investigate it. For these reasons, laxative/diuretic abuse was not included as an independent explanatory variable in this retrospective study, and it was included with the binge-purge behavior. No single variable had a correlation of > 0.52 with other variables, indicating that all variables were relatively independent, such that all variables were included in the following analyses. Creatinine level, an indicator for renal dysfunction and its related hyperkalemia, was excluded from the explanatory variables because it was already included in the blood urea nitrogen to creatinine ratio. Indeed, there was no relationship between creatinine levels and serum potassium levels at admission (p = 0.91) or between creatinine levels and the nadir potassium levels during the refeeding period (p = 0.77).
For the analysis of serum potassium level at admission, six explanatory variables were used, including age, sex, anorexia nervosa subtype, body mass index, blood urea nitrogen to creatinine ratio, and serum albumin level, whereas the treatment-related variables (caloric intake, amount of potassium administered, and rate of weight gain) as well as the above-mentioned six explanatory variables were also used for analysis of nadir hypokalemia during the refeeding period.
Sub-analyses were also repeated using the four additional cohorts: patients with measured initial serum magnesium levels, the group of independent patients, the participants with binge-purge type, and those with restrictive type. Because serum magnesium levels were not measured during the night shift in this facility until December 2013, with the exception of certain special cases, we repeated the analyses using 56 admissions for serum potassium levels at admission and 44 admissions for nadir potassium levels, all of whom had undergone complete blood tests including determination of initial serum magnesium levels. Analyses using only independent patients were conducted because of a potential bias related to consecutive admissions. The first admission for each individual patient was included in this cohort (52 independent patients for initial serum potassium levels and 39 independent patients for nadir hypokalemia during refeeding. To take into account the potential heterogeneity among participants with eating disorders depending on the disorder subtype, we carried out separate comparisons among data for individuals with the restrictive subtype (53 admissions) and for those with the binge-purge subtype (36 admissions) for each explanatory variable using Student’s t test and Fisher’s exact test. The above-mentioned multivariable analyses were also performed for each subtype. Given that the hallmark of refeeding syndrome is refeeding hypophosphatemia [17, 28], the correlation between a decrease in serum phosphorus levels and in potassium levels during refeeding was also investigated.
Excel 2010 (Microsoft, Redmond, WA, USA) with add-on Statcel 3 (OMS Ltd., Tokyo, Japan) was used for all statistical analyses. Two-tailed p-values are reported, and p-values of < .05 were considered statistically significant.